BDBM503513 (2R)-N-{2-[(4-{N-[(7S)-4- fluorobicyclo[4.2.0]octa-1,3,5-trien- 7-yl]-N'-hydroxycarbamimidoyl}- 1,2,5-oxadiazol-3-yl)oxy]ethyl}-2,3- dihydroxypropanamide::US11034661, Example 20

SMILES OC[C@@H](O)C(=O)NCCOc1nonc1\C(N[C@H]1Cc2ccc(F)cc12)=N\O

InChI Key InChIKey=ZOPSLSRLAWFUEE-NWDGAFQWSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 503513   

TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM503513((2R)-N-{2-[(4-{N-[(7S)-4- fluorobicyclo[4.2.0]oct...)
Affinity DataIC50:  302nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent